title: Reply to Boyd et al.
authors.affiliation: University of California The Gladstone Institutes, San Francisco, California.
authors.forename: Marc M
authors.initials: MM
authors.lastname: Solomon
authors.affiliation: Fenway Institute, Fenway Health, Boston, Massachusetts.
authors.forename: Kenneth H
authors.initials: KH
authors.lastname: Mayer
authors.affiliation: University of California.
authors.forename: David V
authors.initials: DV
authors.lastname: Glidden
authors.affiliation: Investigaciones Medicas en Salud, Lima, Peru.
authors.forename: Juan V
authors.initials: JV
authors.lastname: Guanira
authors.affiliation: University of California The Gladstone Institutes, San Francisco, California.
authors.forename: Robert M
authors.initials: RM
authors.lastname: Grant
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage*; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000635:transmission*; D006801:Humans; D008297:Male; D065129:Pre-Exposure Prophylaxis / Q000379:methods*; D013587:Syphilis / Q000150:complications* / Q000635:transmission*
chemical_list: D019380:Anti-HIV Agents